5 entries found
Sort by: Latest |Relevance
05 Sep 2017 description

More than 1 million doses of Gavi-funded cholera vaccines heading to Sierra Leone after severe flooding and landslides

FREETOWN, 5 September 2017 – Half a million people in Sierra Leone will be able to access the life-saving cholera vaccine within weeks, the country’s Ministry of Health and Sanitation announced today.

20 Jan 2016 description
report GAVI Alliance

Cet accord aidera au développement du vaccin jusqu’à son homologation par les agences de réglementation

20 Jan 2016 description
report GAVI Alliance

Agreement will help push vaccine towards regulatory approval

Davos, 20 January 2016 – Gavi, the Vaccine Alliance and Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (known as MSD outside the U.S. and Canada) have signed an agreement to support the provision of a vaccine to protect against future deadly Ebola outbreaks. The agreement, announced today at the World Economic Forum in Davos, will help Merck take the vaccine through licensure and WHO prequalification.

15 Jul 2015 description
report GAVI Alliance

Worryingly low immunisation rates risk further deaths as Ebola recedes

11 Dec 2014 description
report GAVI Alliance

Vaccine Alliance ready to begin procurement as soon as WHO recommends a vaccine for use Ebola in Guinea

Geneva, 11 December 2014 - Plans to purchase millions of doses of an Ebola vaccine to support large-scale vaccination efforts were today agreed by the board of Gavi, the Vaccine Alliance. Today’s decision means that Gavi will be ready to act as soon as a safe, effective vaccine is recommended for use by the World Health Organization.